Andreas Hermes

410 total citations
13 papers, 300 citations indexed

About

Andreas Hermes is a scholar working on Oncology, Epidemiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Andreas Hermes has authored 13 papers receiving a total of 300 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 7 papers in Epidemiology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Andreas Hermes's work include Lung Cancer Research Studies (9 papers), Neuroendocrine Tumor Research Advances (7 papers) and Cancer therapeutics and mechanisms (3 papers). Andreas Hermes is often cited by papers focused on Lung Cancer Research Studies (9 papers), Neuroendocrine Tumor Research Advances (7 papers) and Cancer therapeutics and mechanisms (3 papers). Andreas Hermes collaborates with scholars based in Germany, Spain and United States. Andreas Hermes's co-authors include Martin Reck, Benjamin Waschki, U. Gatzemeier, Roy M. Bremnes, Jan Vilsvik, Ulf Aasebø, Christer Sederholm, Stein Sundstrøm, Lars Thaning and Bengt Bergman and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Thoracic Oncology and Lung Cancer.

In The Last Decade

Andreas Hermes

13 papers receiving 291 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andreas Hermes Germany 7 218 175 132 103 34 13 300
J.R. Fischer Germany 9 247 1.1× 75 0.4× 191 1.4× 78 0.8× 19 0.6× 20 300
B.E. van den Borne Netherlands 6 103 0.5× 37 0.2× 99 0.8× 32 0.3× 25 0.7× 10 210
Tsuneo Shimokawa Japan 9 155 0.7× 35 0.2× 161 1.2× 52 0.5× 25 0.7× 56 294
N. Paillot France 6 277 1.3× 97 0.6× 220 1.7× 96 0.9× 12 0.4× 14 318
Claudia Campani Italy 11 76 0.3× 111 0.6× 47 0.4× 50 0.5× 58 1.7× 41 301
Stacey Petruzella United States 7 105 0.5× 55 0.3× 97 0.7× 63 0.6× 33 1.0× 11 237
Hanako Kuhara Japan 10 117 0.5× 58 0.3× 170 1.3× 98 1.0× 33 1.0× 24 271
Federica de Cicco Italy 10 169 0.8× 128 0.7× 18 0.1× 43 0.4× 21 0.6× 10 256
D. Perroni Italy 8 141 0.6× 42 0.2× 42 0.3× 33 0.3× 78 2.3× 10 205
Masaki Munakata Japan 9 217 1.0× 33 0.2× 156 1.2× 67 0.7× 25 0.7× 39 320

Countries citing papers authored by Andreas Hermes

Since Specialization
Citations

This map shows the geographic impact of Andreas Hermes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Hermes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Hermes more than expected).

Fields of papers citing papers by Andreas Hermes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreas Hermes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Hermes. The network helps show where Andreas Hermes may publish in the future.

Co-authorship network of co-authors of Andreas Hermes

This figure shows the co-authorship network connecting the top 25 collaborators of Andreas Hermes. A scholar is included among the top collaborators of Andreas Hermes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andreas Hermes. Andreas Hermes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
2.
Baños, Oresti, et al.. (2013). PhysioDroid: an app for physiological data monitoring.. 297–304. 1 indexed citations
3.
Hermes, Andreas, Benjamin Waschki, & Martin Reck. (2012). Hyponatremia as prognostic factor in small cell lung cancer – A retrospective single institution analysis. Respiratory Medicine. 106(6). 900–904. 38 indexed citations
4.
Reck, Martin, Andreas Hermes, Eng-Huat Tan, et al.. (2011). Tissue sampling in lung cancer: A review in light of the MERIT experience. Lung Cancer. 74(1). 1–6. 28 indexed citations
5.
Hermes, Andreas, et al.. (2011). Efficacy and safety of bronchoscopic laser therapy in patients with tracheal and bronchial obstruction: a retrospective single institution report. The Clinical Respiratory Journal. 6(2). 67–71. 9 indexed citations
6.
Hermes, Andreas. (2011). Metastasiertes kleinzelliges Bronchialkarzinom ohne nachweisbaren Primärtumor. Pneumologie. 65(11). 671–674. 1 indexed citations
7.
8.
Hermes, Andreas, U. Gatzemeier, Benjamin Waschki, & Martin Reck. (2010). Lactate dehydrogenase as prognostic factor in limited and extensive disease stage small cell lung cancer – A retrospective single institution analysis. Respiratory Medicine. 104(12). 1937–1942. 55 indexed citations
9.
Hermes, Andreas, Benjamin Waschki, U. Gatzemeier, & Martin Reck. (2010). Characteristics, treatment patterns and outcomes of patients with small cell lung cancer—A retrospective single institution analysis. Lung Cancer. 71(3). 363–366. 26 indexed citations
10.
Romain, Ahmed Jérôme, et al.. (2009). Effets d’un réentraînement en endurance au LIPOXmax chez des patients psychiatriques traités par psychotropes. Science & Sports. 24(5). 265–268. 5 indexed citations
11.
Hermes, Andreas, Bengt Bergman, Roy M. Bremnes, et al.. (2008). Irinotecan Plus Carboplatin Versus Oral Etoposide Plus Carboplatin in Extensive Small-Cell Lung Cancer: A Randomized Phase III Trial. Journal of Clinical Oncology. 26(26). 4261–4267. 124 indexed citations
12.
Hermes, Andreas, Bengt Bergman, Roy M. Bremnes, et al.. (2007). A randomized phase III trial of irinotecan plus carboplatin versus etoposide plus carboplatin in patients with small cell lung cancer, extensive disease (SCLC-ED): IRIS-Study. Journal of Clinical Oncology. 25(18_suppl). 7523–7523. 8 indexed citations
13.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J.R. Fischer Breakdown of academic impact, for papers by B.E. van den Borne Breakdown of academic impact, for papers by Tsuneo Shimokawa Breakdown of academic impact, for papers by N. Paillot Breakdown of academic impact, for papers by Claudia Campani Breakdown of academic impact, for papers by Stacey Petruzella Breakdown of academic impact, for papers by Hanako Kuhara Breakdown of academic impact, for papers by Federica de Cicco Breakdown of academic impact, for papers by D. Perroni Breakdown of academic impact, for papers by Masaki Munakata
Rankless by CCL
2026